Newton One Investments’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
– Sell
-60
Closed -$1.29K – 115
2023
Q4
$1.29K Hold
60
– – ﹤0.01% 111
2023
Q3
$1.12K Hold
60
– – ﹤0.01% 119
2023
Q2
$1.52K Hold
60
– – ﹤0.01% 121
2023
Q1
$1.55K Hold
60
– – ﹤0.01% 113
2022
Q4
$1.42K Hold
60
– – ﹤0.01% 113
2022
Q3
$2K Hold
60
– – ﹤0.01% 113
2022
Q2
$2K Hold
60
– – ﹤0.01% 119
2022
Q1
$4K Hold
60
– – ﹤0.01% 114
2021
Q4
$6K Hold
60
– – ﹤0.01% 108
2021
Q3
$8K Hold
60
– – 0.01% 108
2021
Q2
$10K Hold
60
– – 0.01% 104
2021
Q1
$11K Hold
60
– – 0.01% 65
2020
Q4
$12K Buy
+60
New +$12.2K 0.01% 60

Other funds holding TDOC

Newton One Investments's TDOC Position: Q1 2024 in Review

Newton One Investments sold out of Teladoc Health (TDOC) in Q1 2024, closing a stake of 60 shares — an estimated $1.29K sold.

Newton One Investments first reported a position in TDOC in Q4 2020 and held it in 13 quarters. The position peaked at $12K in Q4 2020. 426 funds tracked by Wall St. Rank hold TDOC as of Q1 2024.

  • Newton One Investments reported no remaining Teladoc Health position as of Q1 2024 after selling out during the quarter.
  • Newton One Investments sold 60 Teladoc Health shares in Q1 2024, an estimated $1.29K.
  • Newton One Investments first reported a position in Teladoc Health in Q4 2020 and held it in 13 quarters.
  • Newton One Investments's Teladoc Health position peaked at $12K in Q4 2020.
  • 426 funds tracked by Wall St. Rank held Teladoc Health as of Q1 2024.

Based on Newton One Investments's 13F filing for Q1 2024, filed 16 Apr 2024.